by Iwamoto, T. et al.
Institute of Rheumatology, Tokyo Women's Medical University, Japan
Institute of Rheumatology, Tokyo Women's Medical University, Japan
These data suggest that interferon-gamma in combination with interleukin-1beta/tumor necrosis factor-alpha activates the production of MCP-4/CCL13 from chondrocytes in RA joints, and that secreted MCP-4/CCL13 enhances fibroblast-like synoviocyte proliferation by activating the extracellular signal-regulated kinase mitogen-activated protein kinase cascade.
FEBS J. 2007; 18:4904-12